Finance

Lists
GL9:FRA
Glanbia plc
18,58 €
-0,27%
(-0,050) 1D
9 ოქტ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GL9...
Open
18,73 €
High
18,73 €
Low
18,58 €
Mkt. cap
4,54 მლრდ.
Avg. vol.
35,00
Volume
0,00
Dividend
2,40%
Quarterly dividend
0,11 €
Ex-dividend date
20 აგვ. 2026
P/E ratio
21,46
52-wk high
26,00 €
52-wk low
13,00 €
EPS
0,87 €
No. of employees
5 ათ.
Open
18,73 €
High
18,73 €
Low
18,58 €
Mkt. cap
4,54 მლრდ.
Avg. vol.
35,00
Volume
0,00
Dividend
2,40%
Quarterly dividend
0,11 €
Ex-dividend date
20 აგვ. 2026
P/E ratio
21,46
52-wk high
26,00 €
52-wk low
13,00 €
EPS
0,87 €
No. of employees
5 ათ.
News stories
From web sources and news partners
Profile
Glanbia plc is an Irish multinational nutrition company that owns several consumer brands that produce products such as food supplements and ingredients businesses. Glanbia is headquartered in Kilkenny, Ireland with over 5,500 employees in over 30 countries around the world. Glanbia’s consumer brands and ingredients are sold or distributed in over 130 countries. North America is the company’s largest market, and it also has a presence in Europe, Middle East, Asia-Pacific and Latin America. Glanbia's primary listing is on Euronext Dublin. Glanbia comprises three divisions: Glanbia Nutritionals, Glanbia Performance Nutrition and Joint Ventures. Given the company's origins in the co-operative movement, farmer-suppliers of the company retain a significant interest in the company. Tirlán remains the largest shareholder in Glanbia plc. as of 2022 and retains the right to nominate a number of non-executive directors to the board of the company in line with their mutual Relationship Agreement. Wikipedia
About Glanbia plc
CEOჰიუ მაკგუირ
Employees4,96 ათ.
Founded1997
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
1,01 მლრდ.
1,01 მლრდ.
1,04 მლრდ.
1,04 მლრდ.
Cost of goods sold
742,10 მლნ.
742,10 მლნ.
747,30 მლნ.
747,30 მლნ.
Cost of revenue
742,10 მლნ.
742,10 მლნ.
747,30 მლნ.
747,30 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155,35 მლნ.
155,35 მლნ.
172,50 მლნ.
172,50 მლნ.
Operating expense
175,05 მლნ.
175,05 მლნ.
188,75 მლნ.
188,75 მლნ.
Total operating expenses
917,15 მლნ.
917,15 მლნ.
936,05 მლნ.
936,05 მლნ.
Operating income
92,70 მლნ.
92,70 მლნ.
103,65 მლნ.
103,65 მლნ.
Other non operating income
-550,00 ათ.
-550,00 ათ.
-600,00 ათ.
-600,00 ათ.
EBT including unusual items
47,35 მლნ.
47,35 მლნ.
90,25 მლნ.
90,25 მლნ.
EBT excluding unusual items
88,65 მლნ.
88,65 მლნ.
102,05 მლნ.
102,05 მლნ.
Income tax expense
5,40 მლნ.
5,40 მლნ.
13,35 მლნ.
13,35 მლნ.
Effective tax rate
11,40%
11,40%
14,79%
14,79%
Other operating expenses
1,35 მლნ.
1,35 მლნ.
900,00 ათ.
900,00 ათ.
Net income
41,95 მლნ.
41,95 მლნ.
76,90 მლნ.
76,90 მლნ.
Net profit margin
4,15%
4,15%
7,40%
7,40%
Earnings per share
-
-
-
-
Interest and investment income
650,00 ათ.
650,00 ათ.
700,00 ათ.
700,00 ათ.
Interest expense
-8,00 მლნ.
-8,00 მლნ.
-8,05 მლნ.
-8,05 მლნ.
Net interest expenses
-7,35 მლნ.
-7,35 მლნ.
-7,35 მლნ.
-7,35 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
111,45 მლნ.
111,45 მლნ.
132,25 მლნ.
132,25 მლნ.
Gain or loss from assets sale
18,70 მლნ.
18,70 მლნ.
800,00 ათ.
800,00 ათ.
AI content may include mistakes. Learn more
Google აპები